Baseline and Early Treatment MRI Model for Predicting Complete Pathologic Response to Neoadjuvant Chemoimmunotherapy in Patients With Triple-Negative Breast Cancer

. This MRI-based predictive model could facilitate timely tailoring of clinical regimens after immunotherapy initiation by informing optimal deescalation strategies for responders while prompting therapeutic adaptations for nonresponders.